Coronary C-reactive protein distribution: Its relation to development of atherosclerosis

Atherosclerosis

Volumn 145, Issue 2, 1999, Pages 375-379

  Zhang, Y X ^a,c   Cliff, W J ^a   Schoefl, G I ^a   Higgins, G ^b  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Migrant Health Service   (Australia)

Author keywords

Atherosclerosis; C reactive protein; Confocal microscopy; Immunofluorescence technique

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY BLOOD VESSEL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CADAVER; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NECROSIS; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA;

EID: 0032786558     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00105-7     Document Type: Article

References (27)

1. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930;52:561.
2. Pepys MB. C-reactive protein fifty years on. Lancet 1981;21:653.
3. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (Pentaxins) and serum amyloid A protein. Adv Immunol 1983;34:141.
4. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein (a) as an acute phase protein. Atherosclerosis 1989;78:145.
5. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in active coronary artery disease. Am J Cardiol 1990;65:168.
6. Thompson SG, Kienast J, Pyke S, Haverkate F, Van De Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635.
7. Liuzzo G, Biasuggi LM, Gallimore R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417.
8. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973.
10. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT Nested case-control study. Am J Epidemiol 1996;144:537.
11. Volanakis JE, Kaplan MH. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 1971;136:612.
12. Tsujimoto M, Inoue K, Nojima S. C-reactive protein induced agglutination of lipid suspensions prepared in the presence and absence of phosphatidylcholine. J Biochem 1980;87:1531.
13. Kushner I, Kaplan MH. Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions. J Exp Med 1961;114:961.
14. Volanakis JE, Wirtz KWA. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature (Lond) 1979;281:155.
15. Claus DR, Siegel J, Petras K, Osmand AP, Gewurz H. Interactions of C-reactive protein with the first component of human complement. J Immunol 1977;119:187.
16. De Beer FC, Soutar AK, Baltz ML, Trayner TM, Feinstein A, Pepys MB. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med 1982;156:230.
17. Vlaicu R, Rus HG, Niculescu F, Cristea A. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 1985;55:35.
18. Reynolds GD, Vance RP. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987;111:265.
19. Rowe IF. Immunohistochemical studies of C-reactive protein and apolipoprotein B in inflammatory and arterial lesions. J Pathol 1985;145:241.
20. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 1993;143:164.
21. Mitchinson MJ, Hothersall DC, Brooks PN, De Burbure CY. The distribution of ceroid in human atherosclerosis. J Pathol 1985;145:177.
22. Kushner I, Rakita L, Kaplan MH. Studies of acute-phase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits. J Clin Invest 1963;42:286.
23. Mortensen RF, Osmand AP, Gewurz H. Effects of C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions. J Exp Med 1975;141:821.
24. Wood HF. Effect of C-reactive protein on normal human leukocytes. Proc Soc Exp Biol Med 1951;76:843.
25. Adams CWM. Tissue changes and lipid entry in developing atheroma. In Atherogenesis, Initiating Factors. A Ciba Foundation Symposium 12. New York: Elsevier Press, 1973;5-30.
26. Osborn GR. The incubation period of coronary thrombosis. London: Butterworths, 1963.
27. Schwartz CJ, Mitchell JRA. Cellular infiltration of the human arterial adventitia associated with atheromatous plaques. Circulation 1962;26:73.